Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Phase 1 First in Human Study to Explore AMG 355 as Monotherapy and in Combination with Pembrolizumab in Subjects with Advanced Solid Tumors
Amgen
Dose Escalation: Non-small cell lung cancer (NSCLC), colorectal cancer (CRC), gastric cancer (GC), melanoma (MEL). Dose Confirmation: Lead Indication based on data from dose escalation. Dose Expansion: Tertiary Lymphoid Structure positive (TLS+) CRC, GC, and NSCLC.
1 trial -
Phase 1: Web-based intervention (MyWebQuit) with 1-way text messages
BRIGHT MINDS BIOSCIENCES INC.
Social Anxiety Disorder
1 trial -
Safety and immune responses after vaccination with two investigational RNA-based vaccines against tuberculosis in healthy volunteers
BioNTech SE
Tuberculosis
1 trial -
WT1-sensitized T cells
Evidence Based Cataract Study Group
Leukemia
1 trial -
autologous cell-based delivery
Regeneron Ireland Designated Activity Company (DAC)
Hypoplastic Left Heart Syndrome
1 trial -
cyclophosphamide
Evidence Based Cataract Study Group
Malignant Pleural Mesothelioma (MPM)
1 trial -
Bismuth-based susceptibility-guided treatment
Hospital Authority, Hong Kong
Helicobacter Pylori
1 trial -
Clopidogrel
Evidence Based Cataract Study Group
Coronary Artery Disease
1 trial -
Egg based influenza vaccines
BRIGHT MINDS BIOSCIENCES INC.
Influenza
1 trial -
Pharmacokinetic based dosage change
Cardiff Oncology
Severe Haemophilia A
1 trial -
Reinforcement Based Treatment
BRIGHT MINDS BIOSCIENCES INC.
Drug Abuse
1 trial -
Web-based smoking cessation program
BRIGHT MINDS BIOSCIENCES INC.
Cigarette Smoking
1 trial -
Amino acid based formula
United Therapeutics Europe Ltd
Cow Milk Allergy
1 trial -
Antibiotic selection based on the antibiotic susceptibility testing
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastritis
1 trial -
Dairy based toddler nutrition
United Therapeutics Europe Ltd
Weight Gain
1 trial -
Home based food
Universal Integrated
Malnutrition, Child
1 trial -
Lipid-based nutrient supplement
United Therapeutics Europe Ltd
Malnutrition
1 trial -
Medium-quantity lipid-based nutrient supplement (MQ-LNS)
United Therapeutics Europe Ltd
Undernutrition
1 trial -
Medolac human milk based human milk fortifier (MHMHMF)
NORTHWEST BIOTHERAPEUTICS INC
Infant, Premature, Diseases
1 trial -
Mindfulness meditation based on brain-computer interface
The First People's Hospital of Lianyungang
Atrial Fibrillation
1 trial -
Protocol-based management of perioperative antithrombotic therapy
Peking University Third Hospital
Antithrombotic Therapy
1 trial -
Protocol-based management of perioperative antithrombotic therapy
The First People's Hospital of Lianyungang
Antithrombotic Therapy
1 trial -
bismuth-containing quadral therapy based on antibiotic susceptibility
Shandong University
Helicobacter Pylori
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources